Cargando…
My Data, My Choice? – German Patient Organizations’ Attitudes towards Big Data-Driven Approaches in Personalized Medicine. An Empirical-Ethical Study
Personalized medicine (PM) operates with biological data to optimize therapy or prevention and to achieve cost reduction. Associated data may consist of large variations of informational subtypes e.g. genetic characteristics and their epigenetic modifications, biomarkers or even individual lifestyle...
Autores principales: | Rauter, Carolin Martina, Wöhlke, Sabine, Schicktanz, Silke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900081/ https://www.ncbi.nlm.nih.gov/pubmed/33616768 http://dx.doi.org/10.1007/s10916-020-01702-7 |
Ejemplares similares
-
Application of Big Data and Artificial Intelligence in COVID-19 Prevention, Diagnosis, Treatment and Management Decisions in China
por: Dong, Jiancheng, et al.
Publicado: (2021) -
A Data Preparation Methodology in Data Mining Applied to Mortality Population Databases
por: Pérez, Joaquín, et al.
Publicado: (2015) -
Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model
por: Haberson, Andrea, et al.
Publicado: (2019) -
Semantically Enriched Data Access Policies in eHealth
por: Drozdowicz, Michał, et al.
Publicado: (2016) -
The Association between eHealth Capabilities and the Quality and Safety of Health Care in the Netherlands: Comparison of HIMSS Analytics EMRAM data with Elsevier’s ‘The Best Hospitals’ data
por: van Poelgeest, Rube, et al.
Publicado: (2015)